Page last updated: 2024-11-02

pioglitazone and Carcinoma, Lewis Lung

pioglitazone has been researched along with Carcinoma, Lewis Lung in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mori, A1
Sakurai, H1
Choo, MK1
Obi, R1
Koizumi, K1
Yoshida, C1
Shimada, Y1
Saiki, I1

Other Studies

1 other study available for pioglitazone and Carcinoma, Lewis Lung

ArticleYear
Severe pulmonary metastasis in obese and diabetic mice.
    International journal of cancer, 2006, Dec-15, Volume: 119, Issue:12

    Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Hypoglycemic Agents; Killer Cells, Natural; Leptin

2006